series-a
Stage
2
Investors
About
ArunA Biomedical develops cell-free biologics based on exosomes to treat neurodegenerative disorders and optimize delivery of therapeutic molecules such as RNAs, antibodies, genes, and small molecules.
Explore ArunA Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.